TORONTO, ON / ACCESSWIRE / September 27, 2024 / Quantum BioPharma Ltd. (formerly, FSD Pharma Inc.) (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company ...
Study resultsDREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update 27.09.2024 / 22:30 CET/CESTThe issuer is solely responsible for the content of this ...
SAN DIEGO, CA / ACCESSWIRE / September 27, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe ...
EuCorVac-19 EuCorVac-19, a COVID-19 vaccine candidate developed by EuBiologics and POP Biotechnologies BUFFALO, N.Y., ...
BUFFALO, NY / ACCESSWIRE / September 27, 2024 / POP Biotechnologies (POP BIO), a Buffalo, NY-based biopharmaceutical company, ...
LEO Pharma A/S, a global leader in medical dermatology, today announced positive results from the Phase 2a Mechanism of Action (MoA) trial, which assessed the mechanistic impact of investigational ...
Epitopea, a transatlantic cancer immunotherapy company, and CQDM are proud to announce the launch of a collaborative research project between Epitopea and Université de Montréal (UdeM), a leading ...
Today is European Myeloma Day, a date dedicated to raising awareness of key issues affecting myeloma patients across Europe. This year, Myeloma Patients Europe (MPE) is highlighting the role of ...
Scientists now have a mathematical measure for 250 million manuscripts ~ As part of its commitment to improving transparency in scientific publishing, Open Access science company DeSci Labs has ...
Bayer News - AskBio to collaborate with Belief BioMed to explore the potential of new gene therapies
Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced a new strategic collaboration with ...
Indicated for adult and pediatric patients 12 years of age and older with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) Leiden, the Netherlands, September 26, 2024: Pharming Group ...
Syndicate has today announced the first cohort of awardees of its Collaborative Discovery Programme (CDP) funding.The £3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback